Contraindicated in active malignancy Growth hormone elevation is generally avoided in patients with active or recent malignancy
Molecular Genetics and Metabolism , 2010
Under NICE guidelines, you need a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition 7,8
The article says GLP-1 medications activate GLP-1 receptors on immune cells, which reduces pro-inflammatory cytokine production, and that chronic inflammation is central to endometriosis pathophysiology
For women whose hormonal shifts have disrupted their metabolic balance, GLP-1 therapy can act as a reset a way to restore equilibrium and re-engage the bodys natural systems of appetite and energy regulation
First, semaglutide stimulates the release of insulin from the pancreas in response to elevated blood glucose levels, helping to maintain normal blood sugar homeostasis